US Broker Ratings

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Analysis: Exploring a 26% Potential Upside in the Biopharmaceutical Sector

Kiniksa Pharmaceuticals, Ltd. (NASDAQ: KNSA) has increasingly captured the attention of investors in the healthcare sector. With its focus on developing novel therapies for cardiovascular and other diseases with unmet..

Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring an 82.96% Potential Upside in the Healthcare Sector

Tandem Diabetes Care, Inc. (NASDAQ: TNDM) stands as a dynamic player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $810.83 million, the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: Exploring a 7.4% Potential Upside in Healthcare

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, particularly in the medical care facilities industry, has been garnering attention from investors seeking opportunities in the..

Disc Medicine, Inc. (IRON) Stock Analysis: Unveiling a 53% Potential Upside Amidst a Biotech Revolution

For investors eyeing the healthcare sector, Disc Medicine, Inc. (NASDAQ: IRON) presents a compelling opportunity. With a focus on addressing unmet needs in hematologic diseases, this clinical-stage biopharmaceutical company might..

Adaptive Biotechnologies (ADPT) Stock Analysis: Exploring the 36% Revenue Growth and Future Prospects

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands as a notable player in the burgeoning biotechnology sector, captivating investors with its robust growth trajectory and innovative approaches to healthcare. Headquartered in Seattle,..

Pulse Biosciences, Inc (PLSE) Investor Outlook: Analyzing a 23.60% Potential Upside in the Healthcare Sector

Pulse Biosciences, Inc (NASDAQ: PLSE) is making waves in the healthcare sector with its innovative bioelectric medicine technologies. As a company focused on developing cutting-edge solutions for medical challenges, Pulse..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: Biotechnology Innovator with 11.18% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is generating buzz in the biotechnology sector, offering investors a unique opportunity to engage with a company at the cutting edge of healthcare innovation. With..

Phreesia, Inc. (PHR) Stock Analysis: A 44% Upside Potential Beckons Investors

Phreesia, Inc. (PHR), a key player in the health information services sector, offers a compelling investment opportunity with significant upside potential. The company, which boasts a market cap of $1.42..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 16% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is capturing investor attention with its innovative approach to cardiovascular healthcare and a promising potential upside of 16.05%. Based in Kirkland, Washington, Kestra operates..

NovoCure Limited (NVCR) Stock Report: Exploring the Potential 110% Upside

For investors eyeing opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) offers a fascinating proposition with its pioneering oncology solutions. With a market capitalization of $1.44 billion, NovoCure stands..

MannKind Corporation (MNKD) Stock Analysis: Exploring a Potential 96% Upside

MannKind Corporation (NASDAQ: MNKD) has captured the attention of investors with its robust pipeline and promising market position in the biotechnology sector. With a market cap of $1.7 billion, this..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A Healthcare Pioneer with a 27.65% Upside Potential

BioLife Solutions, Inc. (NASDAQ: BLFS) stands as a formidable player within the healthcare sector, particularly in the niche of medical instruments and supplies. Headquartered in Bothell, Washington, this company has..

GeneDx Holdings Corp. (WGS) Stock Report: Navigating Growth in Genetic Diagnostics with a Promising 8.62% Upside

GeneDx Holdings Corp. (NASDAQ: WGS), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, continues to capture the attention of investors with its innovative approach..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Strong Revenue Growth Fuels Investor Optimism

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), a dynamic player in the biotechnology sector, has been capturing investor interest with its impressive revenue growth of 164.10%. Specializing in dermatological treatments, the company..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring an 18% Potential Upside in Diagnostics

Veracyte, Inc. (VCYT), a leading player in the healthcare diagnostics and research industry, continues to capture investor attention with its innovative genomic testing solutions. Headquartered in South San Francisco, Veracyte..

Neogen Corporation (NEOG) Stock Analysis: A Potential 37% Upside in the Healthcare Diagnostics Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specifically within the diagnostics and research industry, presents a unique opportunity for investors seeking exposure to the burgeoning field..

Viridian Therapeutics (VRDN) Stock Analysis: Exploring the 75% Potential Upside in Biotech

Viridian Therapeutics, Inc. (NASDAQ: VRDN), a promising player in the biotechnology sector, has been catching the eye of investors thanks to its significant potential upside of 75.27%. Headquartered in Waltham,..

Agios Pharmaceuticals (AGIO) Stock Analysis: Exploring a Potential 18.84% Upside for Biotech Investors

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) stands out in the biotech industry with its pioneering work in cellular metabolism. Headquartered in Cambridge, Massachusetts, Agios is making significant strides in developing treatments..

Harmony Biosciences Holdings, Inc. (HRMY) Stock Analysis: A 61% Upside Potential Beckons Investors

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotechnology sector with its innovative approach to treating rare neurological diseases. With a market capitalization of $1.59 billion, Harmony..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential 51.94% Upside Beckons Investors

Investors searching for compelling opportunities in the healthcare sector might do well to consider ICU Medical, Inc. (NASDAQ: ICUI), a notable player in the medical instruments and supplies industry. With..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds